Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic effects of histone deacetylase inhibitors on heart disease
Pusoon Chun
Archives of Pharmacal Research (2020) Vol. 43, Iss. 12, pp. 1276-1296
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Mesangial Cells and Renal Fibrosis
Jinghong Zhao
Advances in experimental medicine and biology (2019), pp. 165-194
Closed Access | Times Cited: 85
Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Himavanth R. Gatla, Nethaji Muniraj, Prashanth Thevkar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 83
The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension
Yeshun Wu, Hongqing Xu, Xiaoming Tu, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 72
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin, Xinxin Yin, Xin Pan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 33
Histone Deacetylase Inhibitors and Diabetic Kidney Disease
Mitchell J. Hadden, Andrew Advani
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2630-2630
Open Access | Times Cited: 72
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
José Luis Morgado‐Pascual, Vanessa Marchant, Raúl R. Rodrigues-Díez, et al.
Mediators of Inflammation (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 64
Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis
Fang Chen, Qi Gao, Wei Ai, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 3, pp. 1001-1012
Open Access | Times Cited: 60
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 45
Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Yuxiang Luo, Huilin Li
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8828-8828
Open Access | Times Cited: 40
Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
Yu Han, Jiali Nie, Dao Wen Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 28
The role of histone deacetylases in cardiac energy metabolism in heart diseases
Qingwen Yu, Guangyuan Zhao, Jingjing Liu, et al.
Metabolism (2023) Vol. 142, pp. 155532-155532
Closed Access | Times Cited: 14
Histone deacetylase (HDACs) inhibitors: Clinical applications
Kumar D. Shanmukha, Harikrishnareddy Paluvai, Santosh K. Lomada, et al.
Progress in molecular biology and translational science (2023), pp. 119-152
Closed Access | Times Cited: 14
The Role of HDACs and HDACi in Cartilage and Osteoarthritis
He Zhang, Lü Ji, Yue Yang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 33
Bibliometric visualization analysis of gut-kidney axis from 2003 to 2022
Sinan Ai, Yake Li, JiaYin Tao, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Mitochondria for Cardiovascular Therapy: A Deep Dive into Drug Targets and Therapeutic Approaches
Martina Semenzato, Déborah Naón
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis
Hanyi Yang, Kai Guo, Peng Ding, et al.
Genes & Diseases (2024) Vol. 11, Iss. 6, pp. 101216-101216
Open Access | Times Cited: 3
Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation
Kelly A. Hyndman, Małgorzata Kasztan, Luciano D. Mendoza, et al.
AJP Renal Physiology (2019) Vol. 316, Iss. 5, pp. F875-F888
Open Access | Times Cited: 28
HDAC inhibitors rescue multiple disease-causing CFTR variants
Frédéric Anglès, Darren M. Hutt, William E. Balch
Human Molecular Genetics (2019) Vol. 28, Iss. 12, pp. 1982-2000
Open Access | Times Cited: 27
The roles of histone deacetylases in kidney development and disease
Hongbing Liu
Clinical and Experimental Nephrology (2021) Vol. 25, Iss. 3, pp. 215-223
Open Access | Times Cited: 23
Epigenetic modifications of Klotho expression in kidney diseases
Jinkun Xia, Wangsen Cao
Journal of Molecular Medicine (2021) Vol. 99, Iss. 5, pp. 581-592
Closed Access | Times Cited: 22
Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury
Keith Long, Zoe Vaughn, Michael D. McDaniels, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 4, pp. 207-215
Open Access | Times Cited: 15
Targeting histone deacetylases for heart diseases
Gang Jin, Kaiyue Wang, Yaohui Zhao, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106601-106601
Closed Access | Times Cited: 9
Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients
Wanmeng Cui, Wenqi Luo, Xiaohui Zhou, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 24
Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
Ling Nie, Yong Liu, Bo Zhang, et al.
Kidney Diseases (2020) Vol. 6, Iss. 4, pp. 226-235
Open Access | Times Cited: 21
Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children With Myocardial Changes
A. V. Каmеnshchyk, Igor Belenuchev, Valentyn Oksenych, et al.
(2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top